|
|
CONSUMER NEWS
RECALLS
COMPLAINT FORM
SCAM ALERTS
Small Claims Guide Class Actions Lemon Laws FAQ Newsletters |
|
|
![]() |
Lipitor Recall Expanded |
|||
|
June 18, 2003
The came as researchers found the Pfizer, Inc. drug helps reduce strokes and heart attacks in patients with Type II diabetes. The FDA said the action is part of its continuing investigation into the counterfeiting of the popular drug. Officials said the FDA's Forensic Chemistry Center in Cincinnati has determined the counterfeit tablets tested so far do, in fact, contain the chemical atorvastatin, the active ingredient of Lipitor. The analysis has not identified any harmful substances in the counterfeit tablets, although analytical testing continues, the FDA said. Patients who have any Lipitor bottles labeled as "Repackaged by: MED-PRO, Inc.; Lexington, NE 68850" should not take the medication and should instead return it to their pharmacy. Lipitor blocks the body's ability to produce cholesterol, thus preventing or reducing the harmful build-up of plaque in artery walls that contributes to heart disease, stroke and other maladies. Lipitor is among the best-selling pharmaceuticals ever developed. Clinical Trial StoppedSo successful was Lipitor in preventing strokes and heart attacks in patients with type II diabetes that a four-year clinical trial was halted mid-stream so that all patients in the study could begin taking the drug, Pfizer announced. The trial included 2,800 diabetes patients in the United Kingdom and Ireland with no history of heart disease or stroke. Diabetics are at high risk of cardiovascular problems because the high levels of blood sugar that accompany diabetes can damage blood vessels. Halting a clinical trial in midstream is unusual but not unprecedented. It occurs when a drug or treatment is so clearly effective that it would be unethical to allow others in the trial to continue taking a placebo or another drug. Another trial of Lipitor, involving patients with normal or slightly elevated cholesterol levels, was halted late last year when patients taking it had fewer fatal coronary incidents and non-fatal heart attacks than patients receiving placebos. |
|||
Back to the top | News |
||||
Advertisement
|
|
||||
|
AUTOMOTIVE Dealers Manufacturers Service Extended Warranties Lemon Laws Recalls Tires Transporters FAMILY Aging Children, Parenting Recalls Dating Education Entertainment Pets Weddings |
FINANCE Annuities Banks Credit Cards Debt Collection Debt Counseling Insurance Investing Loans Mortgages Payday Loans Student Loans Tax Prep HEALTH Drugs, Pharmacies Health Clubs Hearing Care Hospitals Nursing Homes Nutrition, Diets Vision Care Weight Loss |
HOMEOWNERS & RENTERS Appliances Cookware Furniture Home Improvements Lawn & Garden Movers Pools & Spas Realtors, Rental Agents Recalls Utilities ELECTRONICS Cable TV/DBS Cameras Cell Phones Computers Home Electronics Internet Access Local Phone Service Long Distance VoIP |
SHOPPING In-Home Online Retail Stores Sporting Goods Supermarkets Telemarketers TRAVEL Airlines Bus Lines Car Rental Cruises Hotels Travel Agents Trains RESOURCES Class Actions Complaint Form Small Claims Guide Lemon Laws |
CONSUMER NEWS Latest News Automotive Telecom Financial Health Homeowners Scams Seniors Travel More ... RECALLS Automotive Children's Products Drugs Food Household Products Sporting Goods ABOUT US FAQ Privacy Policy Advertise With Us Newsroom Syndication Terms of Use |
Terms of Use Your use of this site constitutes acceptance of the Terms of Use
Copyright © 2003-2008 ConsumerAffairs.com Inc. All Rights Reserved. The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission. |
|